A clinical trial of a candidate for a coronavirus vaccine being developed by Oxford scientists showed remarkable results, raising hope that a preventative treatment for the deadly pandemic may be on the horizon.
As BBC News reported, universities and pharmaceutical companies across the world are racing against time to get a vaccine against SARS-CoV-2 — the official name of the pathogen causing the COVID-19 pandemic — up and running. Normally, developing a vaccine is a process that take years, not weeks or months. But with hundreds of thousands of people dying, time is of the essence when it comes to getting ahead of this particular virus.
Researchers at Oxford have developed a potential vaccine, dubbed ChAdOx1 nCoV-19, that has moved from the development stage to clinical trials involving human test subjects. And in the first round of such trials, the results are promising.
0 comments :
Post a Comment